Audentes Therapeutics, the San Francisco based biotechnology company who are taking virus mediated gene therapy to clinical trial, have today announced that the first patient has been dosed. Preliminary results will be announced in early January.

Read the press release from Audentes Therapeutics here

Read about this trial on clinicaltrials.gov


Read more about Myotubular Trust’s grant awards to Dr Anna Buj-Bello, who established proof of principle for this gene therapy

Dr Ana Buj-Bello